Dr. Katherine Elizabeth Reynolds, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2901 Arlington Loop, Hattiesburg, MS 39401 Phone: 601-268-5144 Fax: 601-268-5149 |
Dr. George Alex Marchbanks, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1000 Turtle Creek Drive, Suite #450, Hattiesburg, MS 39402 Phone: 601-261-2223 |
Alicea Hill, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 6 Ridgeside, Hattiesburg, MS 39402 Phone: 601-942-7996 |
Belle Vue Specialty Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7127 Highway 98, Suite 30, Hattiesburg, MS 39402 Phone: 601-470-2020 Fax: 800-493-5956 |
Hilari Mcfarland, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6096 U S Highway 98 Ste 1a, Hattiesburg, MS 39402 Phone: 601-261-2467 Fax: 601-296-6685 |
Dr. Deborah J Marcev, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3901 Hardy St, Ste. 130, Hattiesburg, MS 39402 Phone: 601-261-3383 Fax: 601-268-5515 |
Green Eye Institute Pa Optometrist Medicare: Medicare Enrolled Practice Location: 2901 Arlington Loop, Hattiesburg, MS 39401 Phone: 601-268-5144 Fax: 601-268-5149 |
Eye Examiners, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 6117 U S Highway 98 Ste 20, Hattiesburg, MS 39402 Phone: 601-264-2006 Fax: 601-264-9030 |
Morgan Eguia, OD Optometrist Medicare: Medicare Enrolled Practice Location: 6152 U S Highway 98 Ste 30, Hattiesburg, MS 39402 Phone: 601-336-8062 |
Dr. Joshua Patrick, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr W, Hattiesburg, MS 39402 Phone: 601-268-5910 Fax: 601-264-0659 |
Lagniappe Eye Care Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 6152 U S Highway 98, Suite 30, Hattiesburg, MS 39402 Phone: 601-336-8062 |
Ronald Mozingo, Od, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6096 U S Highway 98, Suite 1-a, Hattiesburg, MS 39402 Phone: 601-261-2467 Fax: 601-296-6685 |
Mrs. Anna P Armstrong, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6080 U S Highway 98, Hattiesburg, MS 39402 Phone: 601-450-0270 Fax: 601-450-0273 |
Dr. Karah Hill Hiatt, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 102 N 38th Ave Ste I, Hattiesburg, MS 39401 Phone: 601-264-6688 Fax: 601-264-3393 |
Dr. Ann Austin Williams, O. D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 600 W Pine St, Hattiesburg, MS 39401 Phone: 601-545-2020 Fax: 601-583-0120 |
Dr. Curtis J. Shaffer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7148 U S Highway 98, Suite 201, Hattiesburg, MS 39402 Phone: 601-271-2020 Fax: 601-264-2660 |
Hattiesburg Eye Clinic, P.a. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5901 Hwy 49 South, Hattiesburg, MS 39402 Phone: 601-450-4733 |
Rochelle M Hopkins, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-579-5300 Fax: 601-579-5303 |
Dr. John Randolph Marcev, M.S., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6117 U S Highway 98, Suite 20, Hattiesburg, MS 39402 Phone: 601-264-2006 Fax: 601-264-9030 |
Dr. John Mcintosh Turner, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1100 S 28th Ave, Hattiesburg, MS 39402 Phone: 601-268-3937 Fax: 601-268-1375 |
News Archive
PsychoGenics today announced the establishment of an alliance with KineMed, to provide specialized neurogenesis services to complement PsychoGenics' in vivo testing capabilities.
GTx, Inc. today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with prostate cancer receiving androgen deprivation therapy (ADT).
According to a new U.S. study of 1014 adolescents who were 13 to 16 years of age, almost 11 percent had suffered from insomnia at some stage.
According to the findings of a national survey by a major health insurance company, too many Australian parents are oblivious to the fact their children are overweight.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on October 9, 2009, it received a determination letter from The NASDAQ Stock Market notifying the Company that the NASDAQ Hearing Panel (the "Panel") has granted the Company's request to remain listed on NASDAQ, subject to the Company demonstrating compliance with the NASDAQ Listing Rules (the "Listing Rules") on or before December 31, 2009 (the "Exception Period").
› Verified 5 days ago